Chambers SK - Search Results

1

Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.

Jeffery JJ, Lux K, Vogel JS, Herrera WD, Greco S, Woo HH, AbuShahin N, Pagel MD, Chambers SK. Jeffery JJ, et al. Among authors: chambers sk. Exp Biol Med (Maywood). 2014 Apr;239(4):404-13. doi: 10.1177/1535370214522588. Epub 2014 Mar 5. Exp Biol Med (Maywood). 2014. PMID: 24599884 Free PMC article.

2

Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer.

Woo HH, Zhou Y, Yi X, David CL, Zheng W, Gilmore-Hebert M, Kluger HM, Ulukus EC, Baker T, Stoffer JB, Chambers SK. Woo HH, et al. Among authors: chambers sk. Oncogene. 2009 Mar 5;28(9):1176-86. doi: 10.1038/onc.2008.469. Epub 2009 Jan 19. Oncogene. 2009. PMID: 19151756

3

Role of CSF-1 in progression of epithelial ovarian cancer.

Chambers SK. Chambers SK. Future Oncol. 2009 Nov;5(9):1429-40. doi: 10.2217/fon.09.103. Future Oncol. 2009. PMID: 19903070 Free PMC article. Review.

4

Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.

Woo HH, Yi X, Lamb T, Menzl I, Baker T, Shapiro DJ, Chambers SK. Woo HH, et al. Among authors: chambers sk. Mol Cell Biol. 2011 Jan;31(1):215-25. doi: 10.1128/MCB.01031-10. Epub 2010 Oct 25. Mol Cell Biol. 2011. PMID: 20974809 Free PMC article.

5

Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.

Toy EP, Lamb T, Azodi M, Roy WJ, Woo HH, Chambers SK. Toy EP, et al. Among authors: chambers sk. Breast Cancer Res Treat. 2011 Sep;129(2):411-9. doi: 10.1007/s10549-010-1247-7. Epub 2010 Nov 10. Breast Cancer Res Treat. 2011. PMID: 21063905

6

Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.

Chambers SK, Chow HH, Janicek MF, Cragun JM, Hatch KD, Cui H, Laughren C, Clouser MC, Cohen JL, Wright HM, Abu Shahin N, Alberts DS. Chambers SK, et al. Clin Cancer Res. 2012 May 1;18(9):2668-78. doi: 10.1158/1078-0432.CCR-12-0261. Epub 2012 Mar 15. Clin Cancer Res. 2012. PMID: 22421191 Free PMC article. Clinical Trial.

7

Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.

Woo HH, László CF, Greco S, Chambers SK. Woo HH, et al. Among authors: chambers sk. Mol Cancer. 2012 Aug 21;11:58. doi: 10.1186/1476-4598-11-58. Mol Cancer. 2012. PMID: 22909061 Free PMC article.

8

Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA.

Woo HH, Baker T, Laszlo C, Chambers SK. Woo HH, et al. Among authors: chambers sk. Mol Cell Proteomics. 2013 Jun;12(6):1661-77. doi: 10.1074/mcp.M112.025288. Epub 2013 Mar 7. Mol Cell Proteomics. 2013. PMID: 23471483 Free PMC article.

9

Secretory cell expansion with aging: risk for pelvic serous carcinogenesis.

Li J, Ning Y, Abushahin N, Yuan Z, Wang Y, Wang Y, Yuan B, Cragun JM, Chambers SK, Hatch K, Kong B, Zheng W. Li J, et al. Among authors: chambers sk. Gynecol Oncol. 2013 Dec;131(3):555-60. doi: 10.1016/j.ygyno.2013.09.018. Epub 2013 Sep 20. Gynecol Oncol. 2013. PMID: 24060413

10

Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

Gruessner C, Gruessner A, Glaser K, Abushahin N, Laughren C, Zheng W, Chambers SK. Gruessner C, et al. Among authors: chambers sk. Am J Cancer Res. 2014 Jan 15;4(1):61-72. eCollection 2014. Am J Cancer Res. 2014. PMID: 24482739 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters